SCHEMBL26029093

SCHEMBL26029093

Cc1c(C(C)(C)C)cnc2[nH]ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 3/20 0.50
▸ AXL P30530 2/20 0.50
▸ NUDT1 P36639 4/20 0.40
▸ AURKA O14965 3/20 0.37
▸ AURKB Q96GD4 2/20 0.37
▸ INCENP Q9NQS7 2/20 0.37
▸ TPX2 Q9ULW0 2/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ JAK2 O60674 4/20 0.36
▸ JAK1 P23458 4/20 0.36
▸ PRKCA P17252 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ CCNK O75909 1/20 0.36
▸ CDK12 Q9NYV4 1/20 0.36
▸ RPS6KA3 P51812 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10201641 0.84 PRKCI (0.62) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL18012903 0.84 PRKCI (0.49) PRKCIAXLNUDT1AURKAROCK1
SCHEMBL22792992 0.82 PRKCI (0.46) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL30822853 0.82 PRKCI (0.46) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL16154738 0.81 PRKCI (0.45) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL8324165 0.77 PRKCI (0.67) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL22380076 0.77 PRKCI (0.41) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL17047119 0.76 NOTUM (0.41) PRKCIAXLNUDT1JAK2JAK1
SCHEMBL19104289 0.75 PRKCI (0.59) PRKCIAXLNUDT1AURKAAURKB
SCHEMBL24656163 0.75 PRKCI (0.42) PRKCIAXLNUDT1AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242531-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PRKCI 1830/4885AXL 4168/4885NUDT1 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback